News Board

According to the complaint, Phreesia sold investors on a growth story. Its healthcare platform was expanding. AI tools were gaining traction. Pharma marketing demand appeared strong. Network Solutions visibility looked similar to the year before. But investors now allege that picture was misleading. Throughout 2025, according to the complaint, Phreesia touted its Network Solutions business...Read more

Graphic Packaging told investors it had a strong and steady business. Stable margins. Healthy inventory. Big cash flow ahead. But investors now allege that behind the scenes, the packaging giant was facing falling demand, rising costs, and major inventory problems. In February 2025, Graphic Packaging projected up to nearly $9 billion in annual sales and...Read more

FS KKR Capital told investors its credit portfolio was getting stronger. According to the complaint, non-accrual problems were supposedly under control. Executives pointed to portfolio stability, attractive distributions, and improving credit metrics. Shareholders now allege the cracks were already spreading. From May 2024 through early 2025, FS KKR repeatedly claimed it was improving portfolio quality...Read more

POET Technologies told investors it was positioned for the AI chip race. Big customers. Major purchase orders. Strong growth ahead. But according to the complaint, the story behind the scenes was falling apart. In March 2026, POET disclosed it may be treated as a PFIC. The complaint claims that disclosure understated the likelihood and the...Read more

According to the complaint, SES AI told investors it was building the future of batteries with AI. Big partnerships. Massive revenue targets. A non-binding AISPEX MOU targeting up to $45 million. A significant Data Blanket purchase order. A planned Hisun joint venture. A breakthrough platform called Molecular Universe. But the lawsuit claims investors were not...Read more

On June 10, 2026, Judge Valerie Figueredo, United States Magistrate Judge in the United States District Court for the Southern District of New York, signed an order consolidating recent class actions filed on behalf of shareholders of Coty Inc. who were harmed by alleged securities fraud. The consolidated case is captioned In re Coty Inc....Read more

Regencell told investors it was developing traditional Chinese medicine treatments for ADHD and autism. A tiny company with just 12 employees, no approved or salable products, no revenue, and a claimed TCM formula aimed at treating the fundamental cause of ADHD and autism. Then, according to the complaint, the stock went wild. According to the...Read more

Globant told investors Latin America was its next big success story. A $1 billion expansion. Strong demand. Rapid growth. A rising footprint across Brazil, Mexico, and Argentina. But shareholders allege the reality looked very different. The lawsuit says Globant was actually facing declining demand, canceled projects, and clients walking away. In Brazil, its big acquisition...Read more

LKQ told investors its $2.1 billion Uni-Select deal, including FinishMaster, would drive growth and strengthen its market position. According to the complaint, LKQ called it a “compelling strategic fit” with minimal integration risk. But the lawsuit says, FinishMaster was already losing major customers and market share. Investors allegedly had no idea. In February 2023, LKQ...Read more

Babcock & Wilcox told investors it had landed a transformational AI data center power deal worth over $1.5 billion. Then that story got even bigger, with executives raising it to a $2.4 billion contract and pointing to backlog and demand. But investors later learned allegations that cast the deal in a very different light. In...Read more

United Homes told investors it was exploring “strategic alternatives” to maximize shareholder value. It sounded disciplined. Thoughtful. Even shareholder friendly. But the complaint says something else was allegedly happening behind that review. In May 2025, United Homes launched that review and said every option was on the table. By August, executives were still talking about...Read more

Medpace told investors cancellations were “well behaved” and a 1.15 book to bill was still in reach. Growth looked steady. Backlog looked strong. Confidence stayed high. But behind the scenes, that optimism was hiding a different story. Throughout April, July, and October 2025, executives kept repeating that cancellations were under control and that the second...Read more

Stellantis told investors 2025 would be the year growth came back. Electrification was “growing,” margins were supposed to recover, and management said the company was built to win that shift. But behind the scenes, the complaint says Stellantis had badly misread EV demand and wasn’t positioned to turn that push into real profit. In February...Read more

Upstart told investors its AI was getting smarter. Model 22 was supposed to approve more borrowers, lift conversion rates, and push revenue past $1 billion. For months, executives pointed to AI breakthroughs and raised guidance again and again. But behind the scenes, the lawsuit says that same model was overreacting to macro signals, turning far...Read more

On May 27, 2026, two Co-Lead Plaintiffs were appointed in the class action lawsuit captioned Ortolani v. Plug Power Inc., et al., 1:26-cv-00165-MAD-DJS. United States Magistrate Judge in the Northen District of New York, Daniel Stewart, signed the order that also approved Levi & Korsinsky, LLP and Pomerantz LLP as Co-Lead Counsel in the action....Read more